Related Experiment Videos
Hyperamylasemia after post-chemotherapy retroperitoneal lymph node dissection for testis cancer
J Baniel1, I Leibovitch, R S Foster
1Department of Urology, Indiana University Medical Center, Indianapolis, USA.
The Journal of Urology
|October 1, 1995
Summary
Postoperative hyperamylasemia is common after retroperitoneal lymph node dissection for testis cancer. This elevation in amylase is usually mild, reversible, and not indicative of pancreatitis.
Area of Science:
- Oncology
- Surgical Gastroenterology
Background:
- Testis cancer treatment often involves retroperitoneal lymph node dissection (RPLND).
- Postoperative hyperamylasemia is a recognized, though not fully understood, complication.
Purpose of the Study:
- To evaluate the incidence and characteristics of postoperative hyperamylasemia.
- To determine the association of hyperamylasemia with surgical factors and clinical outcomes in patients undergoing RPLND for testis cancer.
Main Methods:
- Prospective evaluation of serum amylase, lipase, and bilirubin levels.
- 39 consecutive patients undergoing post-chemotherapy RPLND were analyzed.
Main Results:
- Hyperamylasemia (41%) and hyperlipasemia (43%) were frequent, peaking at 24 hours postoperatively.
- Elevations were associated with longer and more difficult procedures.
- No clinical evidence of acute pancreatitis was observed.
Conclusions:
- Extended pancreatic retraction during RPLND can cause transient pancreatic enzyme elevation.
- Hyperamylasemia post-RPLND is typically benign and reversible.
- These findings aid in the differential diagnosis of hyperamylasemia in this patient population.